Skip to content
← Back to this collection

PUBLICATIONS · 29514301

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Natl Cancer Inst
Publication date
2018 Oct 1
First author
Depuydt P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Depuydt P
      type
      Author
    2. name
      Boeva V
      type
      Author
    3. name
      Hocking TD
      type
      Author
    4. name
      Cannoodt R
      type
      Author
    5. name
      Ambros IM
      type
      Author
    6. name
      Ambros PF
      type
      Author
    7. name
      Asgharzadeh S
      type
      Author
    8. name
      Attiyeh EF
      type
      Author
    9. name
      Combaret V
      type
      Author
    10. name
      Defferrari R
      type
      Author
    11. name
      Fischer M
      type
      Author
    12. name
      Hero B
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Depuydt P
      type
      Author
    2. name
      Boeva V
      type
      Author
    3. name
      Hocking TD
      type
      Author
    4. name
      Cannoodt R
      type
      Author
    5. name
      Ambros IM
      type
      Author
    6. name
      Ambros PF
      type
      Author
    7. name
      Asgharzadeh S
      type
      Author
    8. name
      Attiyeh EF
      type
      Author
    9. name
      Combaret V
      type
      Author
    10. name
      Defferrari R
      type
      Author
    11. name
      Fischer M
      type
      Author
    12. name
      Hero B
      type
      Author
    bibliography ids
    1. nci-bib-58f0c686c0aa269713b145af
    book metadata
    content sha256
    6dce8056891c630591aec09825473659896a77481cdd3d3872fd32259b9defcf
    document type
    citation
    dois
    1. 10.1093/jnci/djy022
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29514301
    immutable id
    pubmed:29514301@6dce8056891c630591aec09825473659896a77481cdd3d3872fd32259b9defcf
    journal
    abbreviation
    J Natl Cancer Inst
    issn electronic
    1460-2105
    issn print
    0027-8874
    issue
    10
    name
    Journal of the National Cancer Institute
    nlm unique id
    7503089
    pages
    1084-1093
    volume
    110
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29514301
      provenance
      batch id
      ec9444d0f4cade22eb9f
      provider
      NCBI PubMed ESummary
      record sha256
      615fbd5529a4351934cf691f791ff07ad36616996b5dd05bb4bc6ba077ba0443
      response sha256
      6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
      retrieved at
      2026-09-09T23:47:30.975610+00:00
      publication date
      display
      2018 Oct 1
      precision
      day
      year
      2018
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29514301/
      title
      Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

      Preserved source evidence · Independent clinical review pending · Not medical advice